Issue Date: March 31, 2014
Eisai Teams With Liverpool Academics
Eisai, a Japanese pharmaceutical firm, has formed a partnership with Liverpool School of Tropical Medicine and the University of Liverpool to jointly identify new drugs effective against lymphatic filariasis and onchocerciasis, or river blindness. Both diseases, affecting a combined 150 million people worldwide, are forms of filariasis, a parasitic disease caused by threadlike roundworms. The partners will work to develop drug candidates that effectively eliminate the bacteria Wolbachia, which the worms depend on for growth.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society